1. Home
  2. Medical News
  3. Psychiatry and Mental Health
advertisement

Prenatal Cannabis Use Disorder and Postpartum Psychiatric ED Visits

Simplified brain illustration representing postpartum psychiatric emergency visits studied after prenatal cannabis use
11/18/2026

Key Takeaways

  • Among California women delivering live infants, postpartum psychiatric emergency visits were more common with a recorded prenatal CUD diagnosis than with neither CUD nor AUD.
  • The prenatal AUD benchmark group had the highest observed visit proportion and a significantly higher adjusted risk than the group with neither diagnosis.
  • Recorded prenatal CUD became more prevalent across the California delivery cohorts.
Psychiatric emergency care after childbirth raises a question for women diagnosed with cannabis use disorder (CUD) during pregnancy: does a recorded prenatal diagnosis distinguish those who later visit an emergency department for psychiatric care? The diagnosis captures a documented disorder rather than the full range of cannabis exposure, while an emergency visit captures a particular type of postpartum encounter. Investigators compared documented prenatal diagnoses across live-infant deliveries to examine this question.

Investigators assembled annual California cohorts of women delivering live infants in 2016–2021, totaling 2,036,016 women, using statewide linked hospital and emergency department (ED) discharge records. In the Annals of Epidemiology study of prenatal cannabis use disorder, they retrospectively compared women with prenatal CUD, women with prenatal alcohol use disorder (AUD) as a benchmark exposure, and women with neither diagnosis. They assessed postpartum psychiatric ED visits and separately tracked recorded prenatal CUD prevalence across delivery years. No intervention was assigned.

Recorded prenatal CUD became more prevalent across the study years. Postpartum psychiatric ED visits occurred in 10.4% of women with prenatal CUD, 2.7% of women with neither diagnosis, and 15.6% of women with prenatal AUD. These are observed visit proportions, not adjusted comparisons.

Relative to women with neither diagnosis, those with prenatal CUD had an adjusted risk ratio (RR) of 1.39 (95% confidence interval [CI] 1.32–1.47) for a postpartum psychiatric ED visit. Prenatal AUD was also associated with significantly higher adjusted risk against the neither-diagnosis reference group.

These retrospective associations cannot establish that a CUD diagnosis or cannabis exposure caused a psychiatric ED visit. A recorded prenatal CUD diagnosis does not capture all cannabis use during pregnancy, and psychiatric ED visits do not capture all postpartum psychiatric illness or care received elsewhere. The findings therefore apply to documented diagnoses and emergency encounters, not to all prenatal cannabis exposure or postpartum psychiatric care.

The authors concluded that prenatal CUD was associated with higher adjusted risk of postpartum psychiatric ED visits than having neither disorder diagnosed. They called for consistent screening, diagnosis, and treatment among perinatal women with CUD diagnoses. That conclusion reflects an observed association, not a tested screening or treatment intervention.

This content is intended for healthcare professionals for educational purposes. The article and its image were developed with AI assistance and reviewed by members of the ReachMD team prior to publication. Please refer to the original source linked for the complete and most up-to-date information.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free